HSBC closes $1.5B new issue, unlocking its tender offer

HSBC closed a $1.5B offering of 7.625% perpetual contingent convertible securities, enabling a tender offer for up to $1.5B of its 6.000% securities at 100.50% of principal. The new securities have a higher coupon, increasing HSBC's cost of capital.

Original reporting
Published Nov 13, 2026, 5:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$HSBC
Neutral
high confidence
Mentioned
$HSBC
Relevance
7/10
AlphAI data visualization · based on quantisnow.com
Decision brief

The 30-second read

$HSBCNeutralMed
01

Why it matters

The new issue raises HSBC's funding cost, while the tender offers a modest premium to existing holders, creating mixed short‑term price dynamics.

02

Market read

Primary corporate action affecting HSBC's capital structure; relevant for equity and fixed‑income investors.

03

What to watch

Potential impact of upcoming regulatory capital rules on HSBC's hybrid instrument strategy.

Relevance 7/10Novelty 8/10Timing: immediate

Background

HSBC announced the closing of a $1.5B perpetual contingent convertible issuance, meeting the condition to launch a tender for up to $1.5B of its existing 6.000% securities.

Company-level read

Ticker impact

$HSBCNeutralHigh confidence
Context

HSBC closed a $1.5B 7.625% perpetual contingent convertible issue, satisfying the new‑issue condition for its $1.5B tender offer of existing 6.000% securities.

Expected impact

likely slight pressure on HSBC equity as investors price in higher funding costs, while the tender could buoy the subordinated bond segment.

Evidence & confidence

New capital raise of $1.5B is material; the tender price of 100.50% offers a modest premium, but the higher coupon increases funding expense.

Market effects

Banking sector may see modest cost‑of‑capital pressure, but the tender could set a precedent for similar contingent convertible structures.

UK/European banking markets may experience slight repricing of similar hybrid securities.

Limited to investors in HSBC and comparable global banks with hybrid capital.

Counterpoint

The tender premium could attract investors to the 6.000% securities, offsetting any equity downside.

Key entities

  • HSBC Holdings plc

    Global bank issuing the new contingent convertible securities.

Related articles

$HSBCMed

REG - HSBC Holdings PLC - Tender Offer - New Issue Condition Satisfaction

HSBC Holdings PLC announced the satisfaction of the new issue condition for its tender offer, closing a $1.5B offering of 7.625% perpetual subordinated contingent convertible securities. The offer, which aims to manage the company's Tier 1 capital base, involves purchasing up to $1.5B of outstanding 6.000% securities. The offer expires on 19 November 2026, with a settlement date expected on 24 November 2026, unless extended or terminated.

$HSBCMed

REG - HSBC Holdings PLC - Issuance of contingent convertible securities

HSBC Holdings plc issued $1.5 billion in perpetual subordinated contingent convertible securities on November 13, 2026. The securities, with a 7.625% interest rate, were offered under a shelf registration statement filed with the SEC. Application for listing on Euronext Dublin has been made. The securities are not intended for retail investors in the UK or EEA.

$HSBCMedAI 8/10

HSBC Arranges SRTs for $7B Corporate Loans

HSBC is arranging two synthetic risk transfers (SRTs) covering $7B in corporate loans across the US and Asia. SRTs allow banks to transfer loan loss risk to investors, freeing up regulatory capital. HSBC has been refocusing on core Asian markets, including a $14B acquisition of Hang Seng Bank. SRT issuance is at a record pace, with $45B expected this year. BBVA and BNP Paribas are also preparing SRT deals.